Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Neon Therapeutics Shares Are Flashing Brightly after Reporting Predictive Cancer Breakthrough

After announcing publication in the scientific journal Immunity that it had created a 61-fold improvement process for predicting cancer-specific antigens, Neon Therapeutics' stock has traded wildly today, up more than 46% at times on nearly 100-times average daily volume, bu...

Tallgrass Energy Shares Rise 20% on Blackstone Partners Acquisition Deal

Shares of Tallgrass Energy LP traded 20% higher after the firm advised that it entered into a definitive merger agreement with Blackstone Infrastructure Partners to acquire all of the company's publicly held outstanding class A shares for $22.45 per share in cash. Mid...

Explorer Continues Defining 'World-Class Alkaline Gold System' in Fiji

The work the company has conducted to date at the project and the implications are discussed in a Scarsdale Equities report. In a Jan. 3 research note, Scarsdale Equities analyst Mike Niehuser reported that "evidence continues to mount for an alkaline gold system" at ...

Eminent Gold: Driving world class gold discoveries in Nevada

Eminent Gold Corp (TSXV:EMNT) is a Nevada focused gold exploration company pursuing world-class gold discoveries using new concepts and modern exploration methods. The Market online recently sat down with CEO and Director, Paul Sun. The following is a transcription...

Two Stock-Moving Catalysts Expected in March for Biopharma

These events for Axsome Therapeutics are described in an H.C. Wainwright & Co. report. In a Feb. 24 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Axsome Therapeutics Inc. (AXSM:NASDAQ) finished patient enrollment for its INTERCEP...

Viela Bio Shares Trade Higher After Analyst Issues 'Buy' Recommendation

Shares of Viela Bio Inc. rose 20% after an analyst at H.C. Wainwright & Co. initiated coverage of the stock. This morning, shares of clinical-stage biotechnology firm Viela Bio Inc. (VIE:NASDAQ) , which is focused on pioneering treatments for autoimmune and...

FDA Approves First-of-Its-Kind, Adult Pneumonia Antibiotic; September Launch Planned

The drug's features and its developer's commercial plans are discussed in an H.C. Wainwright & Co. report. In an Aug. 20 research note, analyst Ed Arce reported that H.C. Wainwright & Co. raised its target price on Nabriva Therapeutics Plc (NBRV:NASDAQ) to $8 per sh...

Group Ten Delivers World-Class Drill Results for PGM

The world is at an interesting junction. Awash in debt caused by promises that governments cannot possibly fulfill, civil disorder takes place in at least fourteen different countries. The U.S. political system has tied itself into partisan knots in an effort to replay ...

Ohio Industrial Packaging Maker Greif Records 24% Growth in Q3 Revenue; Shares Trading 14% Higher

Shares of global industrial packaging manufacturer Greif Inc. are trading 14% higher today after the company announced Q3/19 earnings. Industrial packaging products manufacturer and services provider Greif Inc. (GEF:NYSE) yesterday announced third quarter 2019 ear...

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...
1 2 3 4 5 6 7 8 9 10 ...